Surgical Complications: Prevention and Management

Management of Unintended and Abnormal Pregnancy: Comprehensive Abortion Care

Volumn , Issue , 2009, Pages 224-251

  Lichtenberg, E Steve ^a,b   Grimes, David A ^c  

^a Family Planning Associates Medical Group Limited   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Angiographic embolization treatment option for refractory atony; Gestational age risk factor for abortion related mortality; Hematometra blood accumulation in uterine cavity; Hysterotomy, associating with high risk of complications; Surgical complications prevention and management; Surgical inexperience and gestations beyond 10 weeks with increased uterine hemorrhage risk; Underestimation of gestational and preventable complications; Uterine arteriovenous malformation (AVM) of endometrium life threatening condition; Uterine atony induced abortion complication

Indexed keywords

EID: 80053265684     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444313031.ch15     Document Type: Chapter

References (185)

1. Cates W Jr, Grimes DA, Schulz KF. The public health impact of legal abortion: 30 years later. Perspect Sex Reprod Health 2003; 35: 25-28.
2. Grimes DA. Estimation of pregnancy-related mortality risk by pregnancy outcome, United States, 1991 to 1999. Am J Obstet Gynecol 2006; 194: 92-94.
3. Bartlett LA, Berg CJ, Shulman HB et al. Risk factors for legal induced abortion-related mortality in the United States. Obstet Gynecol 2004; 103: 729-737.
4. Chang J, Elam-Evans LD, Berg CJ et al. Pregnancy-related mortality surveillance-United States, 1991-1999. MMWR Surveill Summ 2003; 52: 1-8.
5. Hakim-Elahi E, Tovell HM, Burnhill MS. Complications of firsttrimester abortion: a report of 170,000 cases. Obstet Gynecol 1990; 76: 129-135.
6. Henshaw SK. (1999) Unintended pregnancy and abortion: a public health perspective. In: Paul M, Lichtenberg ES, Borgatta L, Grimes DA, Stubblefield PG, eds. A Clinician's Guide to Medical and Surgical Abortion. Churchill Livingstone, New York, 1999, 11-22.
7. Boonstra H, Gold RB, Richards CL, Finer LB. Abortion in Women's Lives. Guttmacher Institute, New York, 2006.
8. Reece EA. Perspectives on obesity, pregnancy, and birth outcomes in the United States: the scope of the problem. Am J Obstet Gynecol 2008; 198: 23-27.
9. Dark AC, Miller L, Kothenbeutel RL, Mandel L. Obesity and second-trimester abortion by dilation and evacuation. J Reprod Med 2002; 47: 226-230.
10. Marchiano DA, Thomas AG, Lapinski R, Balwan K, Patel J. Intraoperative blood loss and gestational age at pregnancy termination. Prim Care Update Ob Gyns 1998; 5: 204-205.
11. O'Connell K, Jones HE, Lichtenberg ES, Paul M. Secondtrimester surgical abortion practices: a survey of National Abortion Federation members. Contraception 2008; 78: 492-499.
12. Grimes DA, Schulz KF. Morbidity and mortality from secondtrimester abortions. J Reprod Med 1985; 30: 505-514.
13. Lawson HW, Frye A, Atrash HK, Smith JC, Shulman HB, Ramick M. Abortion mortality, United States, 1972 through 1987. Am J Obstet Gynecol 1994; 171: 1365-1372.
14. Autry AM, Hayes EC, Jacobson GF, Kirby RS. A comparison of medical induction and dilation and evacuation for second-trimester abortion. Am J Obstet Gynecol 2002; 187: 393-397.
15. Turok DK, Gurtcheff SE, Esplin MS et al. Second trimester termination of pregnancy: a review by site and procedure type. Contraception 2008; 77: 155-161.
16. Kapp N, Todd CS, Yadgarova KT et al. A randomized comparison of misoprostol to intrauterine instillation of hypertonic saline plus a prostaglandin F2α analogue for second-trimester induction termination in Uzbekistan. Contraception 2007; 76:461-466.
17. Goh SE, Thong KJ. Induction of second trimester abortion (12-20 weeks) with mifepristone and misoprostol: a review of 386 consecutive cases. Contraception 2006; 73: 516-519.
18. Green J, Borgatta L, Sia M et al. Intervention rates for placental removal following induction abortion with misoprostol. Contraception 2007; 76: 310-313.
19. Burgoine GA, Van Kirk SD, Romm J, Edelman AB, Jacobson S-L, Jensen JT. Comparison of perinatal grief after dilation and evacuation or labor induction in second trimester terminations for fetal anomalies. Am J Obstet Gynecol 2005; 192: 1928-1932.
20. Virk J, Zhang J, Olsen J. Medical abortion and risk of subsequent adverse pregnancy outcome. N Engl J Med 2007; 357:648-653.
21. Kalish RB, Chasen ST, Rosenzweig LB, Rashbaum WK, Chervenak FA. Impact of midtrimester dilation and evacuation on subsequent pregnancy outcome. Am J Obstet Gynecol 2002; 187:882-885.
22. Chasen ST, Kalish RB, Gupta M, Kaufman J, Chervenak FA. Obstetrical outcomes after surgical abortion at > or = 20 weeks' gestation. Am J Obstet Gynecol 2005; 193: 1161-1164.
23. Jackson JE, Grobman WA, Haney E, Casele H. Mid-trimester dilation and evacuation with laminaria does not increase the risk for severe subsequent pregnancy complications. Int J Gynaecol Obstet 2007; 96: 12-15.
24. Woo J, Fine P, Goetzl L. Abortion disclosure and the association with domestic violence. Obstet Gynecol 2005; 105: 1329-1334.
25. Meirik O, Bergström R. Outcome of delivery subsequent to vacuum-aspiration abortion in nulliparous women. Acta Scand Gynecol Obstet 1983; 62: 499-509.
26. Zhou W, Sorenson HT, Olsen J. Induced abortion and subsequent pregnancy duration. Obstet Gynecol 1999; 94: 948-953.
27. Meyer NL, Addis IB, Lipscomb GH. Ureteral avulsion during uterine dilatation and evacuation: a case report. J Reprod Med 2006; 51: 581-583.
28. Choudhary N, Saha SC, Gopalan S. Abortion procedures in a tertiary care institution in India. Int J Gynaecol Obstet 2005; 91:81-86.
29. Darney PD, Atkinson E, Hirabayashi K. Uterine perforation during second-trimester abortion by cervical dilation and instrumental extraction: a review of 15 cases. Obstet Gynecol 1990; 75: 441-444.
30. Kaunitz AM, Rovira EZ, Grimes DA, Schulz KF. Abortions that fail. Obstet Gynecol 1985; 66: 533-537.
31. Valle RF, Sabbagha RE. Management of first trimester pregnancy termination failures. Obstet Gynecol 1980; 55: 625-629.
32. Edwards J, Carson SA. New technologies permit safe abortion at less than six weeks' gestation and provide timely detection of ectopic gestation. Am J Obstet Gynecol 1997; 176: 1101-1106.
33. Paul ME, Mitchell CM, Rogers AJ, Fox MC, Lackie EG. Early surgical abortion: efficacy and safety. Am J Obstet Gynecol 2002; 187: 407-411.
34. Fulcheri E, di Capua E, Ragni N. Histologic examination of products of conception at the time of pregnancy termination. Int J Gynaecol Obstet 2003; 80: 315-316.
35. Grossman D, Ellertson C, Grimes DA, Walker D. Routine follow-up visits after first-trimester induced abortion. Obstet Gynecol 2004; 103: 738-745.
36. Roshan D. Pregnancy outcomes after failed abortion. Obstet Gynecol 2006; 107(Abstract), 97S.
37. Kurtz AB, Shlansky-Goldberg RD, Choi HY, Needleman L, Wapner RJ, Goldberg BB. Detection of retained products of conception following spontaneous abortion in the first trimester. J Ultrasound Med 1991; 10: 387-395.
38. Bar-Hava I, Aschkenazi S, Orvieto R et al. Spectrum of normal intrauterine cavity sonographic findings after first-trimester abortion. J Ultrasound Med 2001; 20: 1277-1281.
39. Debby A, Golan A, Sadan O, Rotmensch S, Malinger G. Sonographic characteristics of the uterine cavity following firsttrimester uterine evacuation. Ultrasound Obstet Gynecol 2008; 31:555-559.
40. Grimes DA, Schulz KF, Cates W Jr, Tyler CW Jr. Midtrimester abortion by intraamniotic prostaglandin F2α. Safer than saline? Obstet Gynecol 1977; 49: 612-616.
41. Peterson WF, Berry FN, Grace MR, Gulbranson CL. Secondtrimester abortion by dilatation and evacuation: an analysis of 11,747 cases. Obstet Gynecol 1983; 62: 185-190.
42. Hodgson JE, Portmann KC. Complications of 10,453 consecutive first-trimester abortions: a prospective study. Am J Obstet Gynecol 1974; 120: 802-807.
43. Wulff GJ Jr, Freiman SM. Elective abortion. Complications seen in a freestanding clinic. Obstet Gynecol 1977; 49: 351-357.
44. Wadhera S. Early complication risks of legal abortions, Canada, 1975-1980. Can J Public Health 1982; 73: 396-400.
45. Hill NC, MacKenzie IZ. 2308 second trimester terminations using extra-amniotic fluid or intra-amniotic prostaglandin E2: an analysis of efficacy and complications. Br J Obstet Gynaecol 1989; 96: 1424-1431.
46. Hern WM. Serial multiple laminaria and adjunctive urea in late outpatient dilation and evacuation abortion. Obstet Gynecol 1984; 63: 543-549.
47. Altman AM, Stubblefield PG, Schlam JF, Loberfeld R, Osathanodh R. Midtrimester abortion with Laminaria and vacuum evacuation on a teaching service. J Reprod Med 1985; 30:601-606.
48. Jacot FR, Poulin C, Bilodeau AP et al. A five-year experience with second-trimester induced abortions: no increase in complication rate as compared to the first trimester. Am J Obstet Gynecol 1993; 168: 633-637.
49. National Abortion Federation. Summary of abortion statistics. National Abortion Federation, Washington (DC), 1996.
50. Hern WM. Laminaria, induced fetal demise, and misoprostol in late abortion. Int J Gynaecol Obstet 2001; 75: 279-286.
51. Pridmore BR, Chambers DG. Uterine perforation during surgical abortion: a review of diagnosis, management, and prevention. Aust N Z J Obstet Gynaecol 1999; 39: 349-353.
52. Patel A, Talmont E, Morfesis J et al. The Planned Parenthood Federation of America Buccal Misoprostol Waiver Group. Adequacy and safety of buccal misoprostol for cervical preparation prior to termination of second-trimester pregnancy. Contraception 2006; 73: 420-430.
53. Stubblefield PG, Grimes DA. Septic abortion. NEngl J Med 1994; 331: 310-314.
54. Nathanson BN. The postabortal pain syndrome: a new entity. Obstet Gynecol 1973; 41: 739-740.
55. Sands RX, Burnhill MS, Hakim-Elahi E. Postabortal uterine atony. Obstet Gynecol 1974; 43: 595-598.
56. Dean CL, Chez RA. Using vasopressin in paracervical block. Contemp OB/GYN 1993; 38: 42-44.
57. Haddad S, Ruach M, Ohel G. Sonographic demonstration of endometrial fluid collection following termination of pregnancy. Obstet Gynecol 1992; 79: 703-704.
58. Bozorgi N. Statistical analysis of first-trimester pregnancy terminations in an ambulatory surgical center. Am J Obstet Gynecol 1977; 127: 763-768.
59. Hodari AA, Peralta J, Quiroga PJ, Gerbi EB. Dilatation and curettage for second-trimester abortions. Am J Obstet Gynecol 1977; 127: 850-854.
60. Pahl IR, Lundy LE. Experience with midtrimester abortion. Obstet Gynecol 1979; 53: 587-591.
61. Castleman LD, Oanh KT, Hyman AG, Thuy le T, Blumenthal PD. Introduction of the dilation and evacuation procedure for second-trimester abortion in Vietnam using manual vacuum aspiration and buccal misoprostol. Contraception 2006; 74: 272-276.
62. Grimes DA, Kafrissen ME, O'Reilly KR, Binkin NJ. Fatal hemorrhage from legal abortion in the United States. Surg Gynecol Obstet 1983; 157: 461-466.
63. Schulz KF, Grimes DA, Christensen DD. Vasopressin reduces blood loss from second-trimester dilatation and evacuation abortion. Lancet 1985; 2: 353-356.
64. Higier J, Krajewski J, Turowski J, Symonowicz N. The influence of ornithine 8-vasopressin preparation upon blood loss after induced abortions performed under local analgesia. Ginekol Pol 1970; 41: 731-734.
65. O'Brien P, El-Refaey H, Gordon A, Geary M, Rodeck CH. Rectally administered misoprostol for the treatment of postpartum hemorrhage unresponsive to oxytocin and ergometrine: a descriptive study. Obstet Gynecol 1998; 92: 212-214.
66. Hendsch SA, Cohn GM. The safety and efficacy of uterine packing in postpartum hemorrhage: A retrospective study. Obstet Gynecol 2002; 99 (Abstract), 86S.
67. Bobrowski RA, Jones TB. A thrombogenic uterine pack for postpartum hemorrhage. Obstet Gynecol 1995; 85: 836-837.
68. Kauff ND, Chelmow D, Kawada CY. Intractable bleeding managed with Foley catheter tamponade after dilation and evacuation. Am J Obstet Gynecol 1995; 173: 957-958.
69. Marcovici I, Scoccia B. Postpartum hemorrhage and intrauterine balloon tamponade. A report of three cases. J Reprod Med 1999; 44: 122-126.
70. Bakri YN, Amri A, Abdul Jabbar F. Tamponade-balloon for obstetrical bleeding. Int J Gynaecol Obstet 2001; 74: 139-142.
71. Papp Z, Tóth-Pál E, Papp C et al. Hypogastric artery ligation for intractable pelvic hemorrhage. Int J Gynaecol Obstet 2006; 92:27-31.
72. Philippe HJ, d'Oreye D, Lewin D. Vaginal ligature of uterine arteries during postpartum hemorrhage. Int J Gynaecol Obstet 1997; 56: 267-270.
73. B-Lynch C, Coker A, Lawal AH, Abu J, Cohen MJ. The B-Lynch surgical technique for the control of massive postpartum hemorrhage:an alternative to hysterectomy? Br J Obstet Gynaecol 1997; 104: 372-375.
74. Cho JH, Jun HS, Lee CN. Hemostatic suturing technique for uterine bleeding during cesarean delivery. Obstet Gynecol 2000; 96: 129-131.
75. Hayman RG, Arulkumaran S, Steer PJ. Uterine compression sutures: surgical management of postpartum hemorrhage. Obstet Gynecol 2002; 99: 502-506.
76. Pereira A, Nunes F, Pedroso S, Saraiva J, Retto H, Meirinho M. Compressive uterine sutures to treat postpartum bleeding secondary to uterine atony. Obstet Gynecol 2005; 106: 569-572.
77. Baskett TF. Uterine compression sutures for postpartum hemorrhage:efficacy, morbidity, and subsequent pregnancy. Obstet Gynecol 2007; 110: 68-71.
78. Nelson WL, O'Brien JM. The uterine sandwich for persistent uterine atony: combining the B-Lynch compression suture with an intrauterine Bakri balloon. Am J Obstet Gynecol 2007; 196: e9-10.
79. Borgatta L, Chen AY, Reid SK, Stubblefield PG, Christensen DD, Rashbaum WK. Pelvic embolization for treatment of hemorrhage related to spontaneous and induced abortion. Am J Obstet Gynecol 2001; 185: 530-536.
80. Steinauer JE, Diedrich JT, Wilson MW, Darney PD, Vargas JE, Drey EA. Uterine artery embolization in postabortion hemorrhage. Obstet Gynecol 2008; 111: 881-889.
81. Lichtenberg ES. Angiography as treatment for a high cervical tear. A case report. J Reprod Med 2003; 48: 287-289.
82. Taipale P, Hiilesmaa V, Ylöstalo P. Diagnosis of placenta previa by transvaginal sonographic screening at 12-16 weeks in a nonselected population. Obstet Gynecol 1997; 83:364-367.
83. Thomas AG, Alvarez M, Friedman F Jr, Brodman ML, Kim J, Lockwood C. The effect of placenta previa on blood loss in second-trimester pregnancy termination. Obstet Gynecol 1994; 84: 58-60.
84. Halperin R, Vaknin Z, Langer R, Bukovsky I, Schneider D. Late midtrimester pregnancy termination in the presence of placenta previa. J Reprod Med 2003; 48: 175-178.
85. Oyelese Y, Smulian JC. Placenta previa, placenta accreta, and vasa previa. Obstet Gynecol 2006; 107: 927-941.
86. Nakayama D, Masuzaki H, Miura K, Hiraki K, Yoshimura S, Ishimaru T. Effect of placenta previa on blood loss in secondtrimester abortion by labor induction using gemeprost. Contraception 2007; 75: 238-240.
87. Johnson LG, Mueller BA, Daling JR. The relationship of placenta previa and history of induced abortion. Int J Gynaecol Obstet 2003; 81: 191-198.
88. Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation:twenty-year analysis. Am J Obstet Gynecol 2005; 192: 1458-1461.
89. Rashbaum WK, Gates EJ, Jones J, Goldman B, Morris A, Lyman WD. Placenta accreta encountered during dilation and evacuation in the second trimester. Obstet Gynecol 1995; 85:701-703.
90. Silver RM, Landon MB, Rouse DJ et al. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol 2006; 107: 1226-1232.
91. Grobman WA, Gersnoviez R, Landon MB. Pregnancy outcomes for women with placenta previa in relation to the number of prior cesarean deliveries. Obstet Gynecol 2007; 110:1249-1255.
92. Höpker M, Fleckenstein G, Heyl W, Sattler B, Emons G. Placenta percreta in week 10 of pregnancy with consecutive hysterectomy:case report. Hum Reprod 2002; 17: 817-820.
93. Balkanli-Kaplan P, Gucer F, Oz-Puyan F, Yuce MA, Kutlu K. Placenta percreta diagnosed after first-trimester pregnancy termination:a case report. J Reprod Med 2006; 51: 662-664.
94. Walter AJ, McCullough AE, Patel MD, Cornella JL. Placenta increta presenting as a delayed postabortal hemorrhage. Obstet Gynecol 1999; 93: 846.
95. Lerner JP, Deane S, Timor-Tritsch IE. Characterization of placenta accreta using transvaginal sonography and color Doppler imaging. Ultrasound Obstet Gynecol 1995; 5: 198-201.
96. Ludmir J, Holland GA, Bader T et al. The value of magnetic resonance imaging in the evaluation of patients at risk for placenta accreta. SPO abstracts. Am J Obstet Gynecol 1993; 168 (Abstract):429.
97. Warshak CR, Eskander R, Hull AD et al. Accuracy of ultrasonography and magnetic resonance imaging in the diagnosis of placenta accreta. Obstet Gynecol 2006; 108: 573-581.
98. Kayem G, Davy C, Goffinet F, Thomas C, Clément D, Cabrol D. Conservative versus extirpative management in cases of placenta accreta. Obstet Gynecol 2004; 104: 531-536.
99. Morikawa M, Yamada T, Yamada H, Minakami H. Effect of gonadotropin-releasing hormone agonist on a uterine arteriovenous malformation. Obstet Gynecol 2006; 108: 751-753.
100. Hoffman MK, Meilstrup JW, Shackelford DP, Kaminski PF. Arteriovenous malformations of the uterus: an uncommon cause of vaginal bleeding. Obstet Gynecol Surv 1997; 52: 736-740.
101. Wiebe ER, Switzer P. Arteriovenous malformations of the uterus associated with medical abortion. Int J Gynaecol Obstet 2000; 71: 155-158.
102. Halperin R, Schneider D, Maymon R, Peer A, Pansky M, Herman Arteriovenous malformation after uterine curettage: a report of 3 cases. J Reprod Med 2007; 52: 445-449.
103. Goldberg RP, Flynn MK. Pregnancy after medical management of a uterine arteriovenousmalformation. A case report. J Reprod Med 2000; 45: 961-963.
104. Poppe W, Van Assche FA, Wilms G, Favril A, Baert A. Pregnancy after transcatheter embolization of a uterine arteriovenous malformation. Am J Obstet Gynecol 1987; 156:1179-1180.
105. Kafrissen ME, Barke MW, Workman P, Schulz KF, Grimes DA. Coagulopathy and induced abortion methods: rates and relative risks. Am J Obstet Gynecol 1983; 147: 344-345.
106. Hern WM. Laminaria versus Dilapan osmotic cervical dilators for outpatient dilation and evacuation abortion: randomized cohort comparison of 1,001 patients. Am J Obstet Gynecol 1994; 171: 1324-1328.
107. Alfirevic Z, Elbourne D, Pavord S et al. Use of recombinant activated factor VII in primary postpartum hemorrhage: the Northern European Registry 2000-2004. Obstet Gynecol 2007; 110: 1270-1278.
108. Pepas LP, Arif-Adib M, Kadir RA. Factor VIIa in puerperal hemorrhage with disseminated intravascular coagulation. Obstet Gynecol 2006; 108: 757-761.
109. Weiskopf RB, Viele MK, Feiner J et al. Human cardiovascular and metabolic response to acute, severe isovolemic anemia. JAMA 1998; 279: 217-221.
110. Viele MK, Weiskopf RB. What can we learn about the need for transfusion from patients who refuse blood? The experience with Jehovah's Witnesses. Transfusion 1994; 34: 396-401.
111. Heisterberg L, Kringelbach M. Early complications after induced first-trimester abortion. Acta Obstet Gynecol Scand 1987; 66: 201-204.
112. Fried G, Östlund E, Ullberg C, Bygdeman M. Somatic complications and contraceptive techniques following legal abortion. Acta Obstet Gynecol Scand 1989; 68: 515-521.
113. Grimes DA, Schulz KF, Cates W Jr, Tyler CW Jr. Mid-trimester abortion by dilation and evacuation: a safe and practical alternative. N Engl J Med 1977; 296: 1141-1145.
114. Barbacci MB, Spence MR, Kappus EW, Burkman RC, Rao L, Quinn TC. Postabortal endometritis and isolation of Chlamydia trachomatis. Obstet Gynecol 1986; 68: 686-690.
115. Wein P, Kloss M, Garland SM. Postabortal pelvic sepsis in association with Chlamydia trachomatis. Aust N Z J Obstet Gynaecol 1990; 30: 347-350.
116. Blackwell AL, Thomas PD, Wareham K, Emery SJ. Health gains from screening for infection of the lower genital tract in women attending for termination of pregnancy. Lancet 1993; 342: 206-210.
117. Larsson PG, Bergman B, Forsum U, Platz-Christensen JJ, P°ahlson C. Mobiluncus and clue cells as predictors of PID after first-trimester abortion. Acta Obstet Gynecol Scand 1989; 68:217-220.
118. Lundh C, Meirik O, Nygren K-G. Vaginal cleansing at vacuum abortion does not reduce risk of postoperative infection. Acta Obstet Gynecol Scand 1983; 62: 275-277.
119. Varli IH, Lindelius A, Bergström A. Is preoperative vaginal cleansing necessary for control of infection after first trimester vacuum curettage? Acta Obstet Gynecol Scand 2005; 84:650-653.
120. Sawaya GF, Grady D, Kerlikowske K, Grimes DA. Antibiotics at the time of induced abortion: the case for universal prophylaxis based on a meta-analysis. Obstet Gynecol 1996; 87:884-890.
121. Miller WC, Ford CA, Morris M et al. Prevalence of chlamydial and gonococcal infections among young adults in the United States. JAMA 2004; 291: 2229-2236.
122. Datta SD, Sternberg M, Johnson RE. Gonorrhea and chlamydia in the United States among persons 14 to 39 years of age, 1999 to 2002. Ann Intern Med 2007; 147: 89-96.
123. Patel AA. Prevalence of chlamydia and gonorrhea in a public pregnancy termination clinic. Contraception 2007; 76(Abstract):166.
124. Royal College of Obstetricians and Gynaecologists. The Care of Women Requesting Induced Abortion. Evidence-based clinical guideline number 7. RCOG Press, London, 2004.
125. Ness RB, Trautmann G, Richter HE. Effectiveness of treatment strategies in some women with pelvic inflammatory disease: a randomized trial. Obstet Gynecol 2005; 106: 573-580.
126. Paik CK, Waetjen LE, Xing G, Sweet RL. Epidemiology of pelvic inflammatory disease and tubo-ovarian abscess, 1991-2001. Obstet Gynecol 2005; 105(Abstract): 23S.
127. Petit P, Bréard J, Montalescot V et al. Lethal toxin from Clostridium sordellii induces cell apoptotic death by disruption of mitochondrial homeostasis in HL-60 cells. Cell Microbiol 2003; 5:761-777.
128. Sutkin G, Capelle SD, Schlievert PM, Creinin MD. Toxic shock syndrome after laminaria insertion. Obstet Gynecol 2001; 98:959-961.
129. Mourton S, Rich W. Group A streptococcal toxic shock syndrome after an office endometrial biopsy: a case report. J Reprod Med 2006; 51: 665-668.
130. Cohen AL, Bhatnagar J, Reagan S. Toxic shock associated with Clostridium sordellii and Clostridium perfringens after medical and spontaneous abortion. Obstet Gynecol 2007; 110:1027-1033.
131. Sinave C, Le Templier G, Blouin D et al. Toxic shock syndrome due to Clostridium sordellii: a dramatic postpartum and postabortion disease. Clin Infect Dis 2002; 35: 1441-1443.
132. Fischer M, Bhatnagar J, Guarner J et al. Fatal toxic shock syndrome associated with Clostridium sordellii after medical abortion. N Engl J Med 2005; 353: 2352-2360.
133. Rørbye C, Petersen IS, Nilas L. Postpartum Clostridium sordellii infection associated with fatal toxic shock syndrome. Acta Obstet Gynecol Scand 2000; 79: 1134-1135.
134. Aldape MJ, Bryant AE, Stevens DL. Clostridium sordellii infection:epidemiology, clinical findings, and current perspectives on diagnosis and treatment. Clin Infect Dis 2006; 43: 1436-1446.
135. Lichtenberg ES, Henning C. Conservative management of clostridial endometritis. Am J Obstet Gynecol 2004; 191: 266-270.
136. Walker CK, Landers DV. Pelvic abscesses: new trends in management. Obstet Gynecol Surv 1991; 46: 615-624.
137. Taylor KJ,Wasson JR, DeGraaff C, Rosenfield AT, Andriole VT. Accuracy of grey-scale ultrasound diagnosis of abdominal and pelvic abscesses in 220 patients. Lancet 1978; 1: 83-84.
138. Reed SD, Landers DV, Sweet RL. Antibiotic treatment of tuboovarian abscess: comparison of broad-spectrum beta-lactam agents versus clindamycin-containing regimens. Am J Obstet Gynecol 1991; 164: 1556-1562.
139. Stubblefield PG, Borgatta L. Complications of induced abortion. In: Pearlman MD, Tintinali JE, Dyne PL, eds. Obstetric and Gynecologic Emergencies: Diagnosis and Management. McGraw-Hill, New York, 2004.
140. Palys EE, Li J, Gaut PL, Hardy WD. Tricuspid valve endocarditis with Group B Streptococcus after an elective abortion: the need for new data. Infect Dis Obstet Gynecol 2006; 43253.
141. American College of Obstetricians and Gynecologists. Antibiotic prophylaxis for gynecologic procedure. ACOG Practice Bulletin No. 74. Obstet Gynecol 2006; 108: 225-234.
142. Jeppson PC, Park A, Chen CCG. Multivalvular bacterial endocarditis after suction curettage abortion. Obstet Gynecol 2008; 112: 452-455.
143. Schulz KF, Grimes DA, Cates W Jr. Measures to prevent cervical injury during suction curettage abortion. Lancet 1983; 1:1182-1185.
144. Lowensohn R, Ballard C. Cervicovaginal fistula: an apparent increased incidence with prostaglandin F2 alpha. Am J Obstet Gynecol 1974; 119: 1057-1061.
145. Townsend DE, Barbis SD, Mathews RD. Vasopressin and operative hysteroscopy in the management of delayed postabortion and postpartum bleeding. Am J Obstet Gynecol 1991; 165: 616-618.
146. Goldrath MH. Uterine tamponade for the control of acute uterine bleeding. Am J Obstet Gynecol 1983; 147: 869-872.
147. Grimes DA, Schulz KF, Cates W Jr. Prevention of uterine perforation during curettage abortion. JAMA 1984; 251: 2108-2111.
148. MacKay HT, Schulz KF, Grimes DA. Safety of local versus general anesthesia for second-trimester dilatation and evacuation abortion. Obstet Gynecol 1985; 66: 661-665.
149. Kaali SG, Szigetvari IA, Bartfai GS. The frequency and management of uterine perforations during first-trimester abortions. Am J Obstet Gynecol 1989; 161: 406-408.
150. White MK, Ory HW, Goldenberg LA. A case-control study of uterine perforations documented at laparoscopy. Am J Obstet Gynecol 1977; 129: 623-625.
151. Chi I, Feldblum P. Uterine perforation during sterilization by laparoscopy and minilaparotomy. Am J Obstet Gynecol 1981; 139: 735-736.
152. Freiman SM, Wulff GJ Jr. Management of uterine perforation following elective abortion. Obstet Gynecol 1977; 50: 647-650.
153. Lindell G, Flam F. Management of uterine perforations in connection with legal abortions. Acta Obstet Gynecol Scand 1995; 74:373-375.
154. De La Vega GA, Nemiroff R, Debbs R. Complications of secondtrimester dilation and evacuation. Obstet Gynecol 2007; 109 (Abstract): 21S.
155. Givens VM, Lipscomb GH. Retained fetal parts after elective second-trimester dilation and evacuation. Obstet Gynecol 2007; 109: 526-527.
156. Imoedemhe DA, Ezimokhai M, Okpere EE, Aboh IF. Intestinal injuries following induced abortion. Int J Gynaecol Obstet 1984; 22: 303-306.
157. Jhobta RS, Attri AK, Jhobta A. Bowel injury following induced abortion. Int J Gynaecol Obstet 2007; 96: 24-27.
158. Sharma JB, Malhotra M, Pundir P. Laparoscopic oxidized cellulose (Surgicel) application for small uterine perforations. Int J Gynaecol Obstet 2003; 83: 271-275.
159. Lajinian S, Margono F, Mroueh J. Sonographic appearance of suspected iatrogenic uterine perforation: A case report. J Reprod Med 1994; 39: 911-912.
160. Soderstrom RM. Bowel injury litigation after laparoscopy. J Am Assoc Gynecol Laparosc 1993; 1: 74-77.
161. Baggish MS. One-hundred and thirty small and large-bowel injuries associated with gynecologic laparoscopic operations. J Gynecol Surg 2007; 23: 83-95.
162. Darney PD, Sweet RL. Routine intraoperative ultrasonography for second trimester abortion reduces incidence of uterine perforation. J Ultrasound Med 1989; 8: 71-75.
163. Chen LH, Lai SF, Lee WH, Leong NK. Uterine perforation during elective first trimester abortions: a 13-year review. Singapore Med J 1995; 36: 63-67.
164. Lichtenberg ES, Frederiksen MC. Cesarean scar dehiscence as a cause of hemorrhage after second-trimester abortion by dilation and evacuation. Contraception 2004; 70: 61-64.
165. Lo ST, Ramsay P, Pierson R, Manconi F, Munro MG, Fraser IS. Endometrial thickness measured by ultrasound scan in women with uterine outlet obstruction due to intrauterine or upper cervical adhesions. Hum Reprod 2008; 23: 306-309.
166. Luk J, Allen RA, Schantz-Dunn J, Goldberg AB. Intrauterine adhesions as a risk factor for failed first-trimester pregnancy termination. Contraception 2007; 76: 331-333.
167. Hakim-Elahi E. Postabortal amenorrhea due to cervical stenosis. Obstet Gynecol 1976; 48: 723-724.
168. Chapman K, Chapman R. Asherman's syndrome: a review of the literature, and a husband and wife's 20-year worldwide experience. J R Soc Med 1990; 83: 576-580.
169. March CM, Israel R. Intrauterine adhesions secondary to elective abortion. Hyseteroscopic diagnosis andmanagement. Obstet Gynecol 1976; 48: 422-424.
170. Knopman J, Copperman AB. Value of 3D ultrasound in the management of suspected Asherman's syndrome. J Reprod Med 2007; 52: 1016-1022.
171. Valle RF, Sciarra JJ. Intrauterine adhesions: hysteroscopic diagnosis, classification, treatment, and reproductive outcome. Am J Obstet Gynecol 1988; 158: 1459-1470.
172. Krivak TC, Zorn KK. Venous thromboembolism in obstetrics and gynecology. Obstet Gynecol 2007; 109: 761-777.
173. Lawson HW, Atrash JK, Franks AL. Fatal pulmonary embolism during legal induced abortion in the United States from 1972 to 1985. Am J Obstet Gynecol 1990; 162: 986-990.
174. Kimball AM, Hallum AV, Cates W Jr. Deaths caused by pulmonary thromboembolism after legally induced abortion. Am J Obstet Gynecol 1978; 132: 169-174.
175. Doyle NM, Ramirez MM, Mastrobattista JM, Monga M, Wagner LK, Gardner MO. Diagnosis of pulmonary embolism: a cost-effectiveness analysis. Am J Obstet Gynecol 2004; 191: 1019-1023.
176. Clark SL, Hankins GDV, Dudley DA, Didly GA, Porter TF. Amniotic fluid embolism: analysis of the national registry. Am J Obstet Gynecol 1995; 172: 1158-1169.
177. Guidotti RJ, Grimes DA, Cates W Jr. Fatal amniotic fluid embolism during legally induced abortion, United States, 1972 to 1978. Am J Obstet Gynecol 1981; 141: 257-261.
178. Hawes CS, Suskin HA, Petropoulos A, Latham SE, Mueller UW. A morphologic study of trophoblast isolated from peripheral blood of pregnant women. Am J Obstet Gynecol 1994; 170: 1297-1300.
179. Clark SL, Pavlova Z, Greenspoon J, Horensten J, Phelan JP. Squamous cells in the maternal pulmonary circulation. Am J Obstet Gynecol 1986; 154: 104-106.
180. Lee W, Ginsburg KA, Cotton DB, Kaufman RH. Squamous and trophoblastic cells in the maternal pulmonary circulation identified by invasive hemodynamic monitoring during the peripartum period. Am J Obstet Gynecol 1986; 155: 999-1001.
181. Clark SL. New concepts of amniotic fluid embolism: a review. Obstet Gynecol Surv 1990; 45: 360-368.
182. Gei A, Hankins GDV. Amniotic fluid embolism: An update. Contemp OB/GYN 2000; 45: 53-66.
183. Ellis AK, Day JH. Incidence and characteristics of biphasic anaphylaxis:a prospective evaluation of 103 patients. Ann Allergy Asthma Immunol 2007; 98: 64-69.
184. Grubb BP. Neurocardiogenic syncope and related disorders of orthostatic intolerance. Circulation 2005; 111: 2997-3006.
185. Hendler I, Schatz M, Momirova V et al. Association of obesity with pulmonary and nonpulmonary complications of pregnancy in asthmatic women. Obstet Gynecol 2006; 108:77-82.